HIV, Buprenorphine, and the Criminal Justice System (STRIDE)
Sponsor: George Mason University
A NA clinical study on Acquired Immunodeficiency Syndrome and Drug Dependence, this trial is completed. The trial is conducted by George Mason University and has accumulated 11 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
Jun 2020 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Sep 2018 — Jun 2020 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Feb 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- George Mason University
- Howard University
- National Institute on Drug Abuse (NIDA)
- Yale University
For direct contact, visit the study record on ClinicalTrials.gov .